Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:GRO

Agria Co. American Depo (GRO) Stock Price, News & Analysis

About Agria Co. American Depo Stock (NYSE:GRO)

Advanced Chart

Key Stats

Today's Range
$1.46
$1.74
50-Day Range
N/A
52-Week Range
$0.71
$1.66
Volume
792,679 shs
Average Volume
36,354 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50
Consensus Rating
Strong Buy

Company Overview

Receive GRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agria Co. American Depo and its competitors with MarketBeat's FREE daily newsletter.

GRO Stock News Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
See More Headlines

GRO Stock Analysis - Frequently Asked Questions

Agria Co. American Depo (GRO) raised $71 million in an IPO on Tuesday, November 26th 2024. The company issued 4,300,000 shares at $15.00-$18.00 per share. Cantor, Bradesco BBI, Freedom Capital Markets and Roth Capital Partners served as the underwriters for the IPO and Clarksons Securities was co-manager.

Agria Co. American Depo's lock-up period expired on Monday, May 26th. Agria Co. American Depo had issued 2,000,000 shares in its initial public offering on November 27th. The total size of the offering was $30,000,000 based on an initial share price of $15.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the expiration of the lock-up period.

Based on aggregate information from My MarketBeat watchlists, some other companies that Agria Co. American Depo investors own include Allena Pharmaceuticals (ALNA), Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Ampio Pharmaceuticals (AMPE), Amarin (AMRN), Ampliphi Biosciences (APHB) and ArQule (ARQL).

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NYSE:GRO
CIK
1413257
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$5.50
Low Price Target
$5.50
Potential Upside/Downside
+276.7%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NYSE:GRO) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners